Eli Lilly and Company
Anti-TrkA antibody
Last updated:
Abstract:
Antibodies to tropomysin receptor kinase (TrkA), compositions including such antibodies, and methods of using such antibodies for the treatment of pain including post-surgical pain, rheumatoid arthritis pain, neuropathic pain and osteoarthritis pain.
Status:
Grant
Type:
Utility
Filling date:
21 Feb 2019
Issue date:
14 Apr 2020